The results of Cell Counting Kit-8 (CCK-8) assays showed that the abrogation of DUSP4 sensitized BC cells to DOX (Fig. 4b, c), and the results of western blotting confirmed the RNA interference efficiency of small interfering RNA (siRNA) targeting DUSP4 (Fig. 4d). The gene discussed is DUSP4; the disease is breast cancer.